 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Audentes Therapeutics Inc. (BOLD)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-02-25 Sale | 2019-02-27 4:31 pm | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 21,000 | $30 | $630,000 | 118,700 (Indirect Direct) | View |
| 2019-02-25 Sale | 2019-02-27 4:32 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $30.06 | $300,553 | 18,236 (Direct) | View |
| 2019-03-25 Sale | 2019-03-27 5:03 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 21,558 | $36 | $776,073 | 0 (Indirect Direct) | View |
| 2019-05-13 Sale | 2019-05-15 4:42 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $36.98 | $369,798 | 18,236 (Direct) | View |
| 2019-06-24 Sale | 2019-06-26 4:07 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 21,000 | $37.79 | $793,614 | 15,678 (Indirect Direct) | View |
| 2019-08-12 Sale | 2019-08-14 7:03 pm | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 20,000 | $34.04 | $680,835 | 115,368 (Indirect Direct) | View |
| 2019-09-23 Sale | 2019-09-25 6:11 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 11,000 | $32.16 | $353,798 | 14,678 (Indirect Direct) | View |
| 2019-11-08 Sale | 2019-11-12 5:32 pm | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 14,426 | $30 | $432,780 | 113,394 (Indirect Direct) | View |
| 2019-12-23 Sale | 2019-12-27 4:10 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 11,000 | $59.6 | $655,589 | 13,678 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-02-25 Exercise | 2019-02-27 4:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 17,000 | $0.78 | 118,700 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 4,000 | $2.19 | 118,700 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:31 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 17,000 | $0.78 | 118,700 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:31 pm | N/A 2025-02-04 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 4,000 | $2.19 | 118,700 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 18,236 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:32 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 18,236 (Direct) | View |
| 2019-03-28 Option Award | 2019-04-01 5:54 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A VP | 37,333 | $0 | 104,000 (Direct) | View |
| 2019-03-28 Option Award | 2019-04-01 5:54 pm | N/A 2029-03-28 | Audentes Therapeutics Inc. | BOLD | Meltz Mark A VP | 104,000 | $37.26 | 104,000 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:42 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 18,236 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:42 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 18,236 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:40 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 1,009 | $37.31 | 22,324 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:41 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 1,009 | $37.31 | 55,714 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:41 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 3,332 | $37.31 | 115,368 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:42 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 757 | $37.31 | 17,479 (Direct) | View |
| 2019-07-15 Option Award | 2019-07-17 4:26 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP Chief Medical Officer | 30,000 | $0 | 90,000 (Direct) | View |
| 2019-07-15 Option Award | 2019-07-17 4:26 pm | N/A 2029-07-15 | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP Chief Medical Officer | 90,000 | $36.08 | 90,000 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-14 7:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 20,000 | $9.5 | 115,368 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-14 7:03 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 20,000 | $9.5 | 115,368 (Direct) | View |
| 2019-09-05 Tax Withholding | 2019-09-09 4:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 505 | $31.02 | 55,209 (Direct) | View |
| 2019-09-05 Tax Withholding | 2019-09-09 4:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 1,974 | $31.02 | 113,394 (Direct) | View |
| 2019-09-05 Tax Withholding | 2019-09-09 4:06 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 505 | $31.02 | 21,819 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-12 5:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 14,426 | $9.5 | 113,394 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-12 5:32 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 14,426 | $9.5 | 113,394 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:15 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 505 | $59.21 | 54,704 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:16 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 1,974 | $59.21 | 111,420 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:17 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 505 | $59.21 | 21,314 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:02 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP Chief Medical Officer | 5,416 | $59.37 | 24,584 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 8,681 | $59.37 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 45,726 | $2.7649 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 5,715 | $9.4988 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 74,117 | $15.26 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 6,891 | $27.39 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 14,895 | $24.74 | 50,105 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 88,928 | $59.37 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 45,726 | $2.7649 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 5,715 | $9.4988 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A 2027-01-25 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 74,117 | $15.26 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A 2027-11-16 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 6,891 | $27.39 | 50,105 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 14,895 | $24.74 | 50,105 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A VP | 4,628 | $59.37 | 32,705 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP Chief Commercial Officer | 4,881 | $59.37 | 26,919 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 8,681 | $59.37 | 148,498 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 41,321 | $2.7649 | 148,498 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 21,458 | $59.37 | 148,498 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:05 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 41,321 | $2.7649 | 148,498 (Direct) | View |
| 2019-12-26 Gift | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 12,500 | $0 | 188,334 (Direct) | View |
| 2019-12-26 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 64,751 | $0.78 | 188,334 (Direct) | View |
| 2019-12-26 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 74,297 | $2.19 | 188,334 (Direct) | View |
| 2019-12-26 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 11,824 | $9.5 | 188,334 (Direct) | View |
| 2019-12-26 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 11,666 | $15.26 | 188,334 (Direct) | View |
| 2019-12-26 Exercise | 2020-01-10 6:18 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 64,751 | $0.78 | 188,334 (Direct) | View |
| 2019-12-26 Exercise | 2020-01-10 6:18 pm | N/A 2025-02-04 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 74,297 | $2.19 | 188,334 (Direct) | View |
| 2019-12-26 Exercise | 2020-01-10 6:18 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 11,824 | $9.5 | 188,334 (Direct) | View |
| 2019-12-26 Exercise | 2020-01-10 6:18 pm | N/A 2027-01-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 11,666 | $15.26 | 188,334 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 144,669 | $2.7649 | 73,781 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 6,219 | $15.26 | 73,781 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 144,669 | $2.7649 | 73,781 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A 2027-01-25 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 6,219 | $15.26 | 73,781 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:26 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP Chief Medical Officer | 24,584 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:26 pm | N/A 2029-07-15 | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP Chief Medical Officer | 90,000 | $36.08 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:27 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Goldberg Mark Alan Director | 1,500 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:27 pm | N/A 2028-01-01 | Audentes Therapeutics Inc. | BOLD | Goldberg Mark Alan Director | 18,000 | $33.91 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:27 pm | N/A 2028-01-18 | Audentes Therapeutics Inc. | BOLD | Goldberg Mark Alan Director | 4,500 | $38 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:27 pm | N/A 2028-06-08 | Audentes Therapeutics Inc. | BOLD | Goldberg Mark Alan Director | 10,000 | $38.65 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:27 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Goldberg Mark Alan Director | 16,200 | $24.74 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:29 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 104,439 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:29 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 110,703 | $2.7649 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:29 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 548 | $9.4988 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:29 pm | N/A 2027-01-25 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 40,883 | $15.26 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:29 pm | N/A 2027-11-16 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 93,109 | $27.39 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:29 pm | N/A 2028-05-07 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 25,000 | $36.39 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:29 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. COO | 50,105 | $24.74 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:30 pm | N/A 2027-06-12 | Audentes Therapeutics Inc. | BOLD | Jarrett Jennifer Director | 18,000 | $14.7 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:30 pm | N/A 2027-10-08 | Audentes Therapeutics Inc. | BOLD | Jarrett Jennifer Director | 9,000 | $26.15 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:30 pm | N/A 2028-06-08 | Audentes Therapeutics Inc. | BOLD | Jarrett Jennifer Director | 10,000 | $38.65 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:30 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Jarrett Jennifer Director | 16,200 | $24.74 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 265,799 | $60 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 13,678 | $60 | 0 (Indirect) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 32,343 | $60 | 0 (Indirect) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 3,555 | $60 | 0 (Indirect) | View |
| 2020-01-15 Disposition | 2020-01-15 1:31 pm | N/A 2026-08-24 | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 18,000 | $15.03 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:31 pm | N/A 2027-10-08 | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 9,000 | $26.15 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:31 pm | N/A 2028-06-08 | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 10,000 | $38.65 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:31 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 16,200 | $24.74 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A VP | 32,705 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:32 pm | N/A 2029-03-28 | Audentes Therapeutics Inc. | BOLD | Meltz Mark A VP | 104,000 | $37.26 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:33 pm | N/A 2025-12-26 | Audentes Therapeutics Inc. | BOLD | Morrison Scott W Director | 33,635 | $9.4988 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:33 pm | N/A 2026-08-24 | Audentes Therapeutics Inc. | BOLD | Morrison Scott W Director | 9,000 | $15.03 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:33 pm | N/A 2027-10-08 | Audentes Therapeutics Inc. | BOLD | Morrison Scott W Director | 9,000 | $26.15 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:33 pm | N/A 2028-06-08 | Audentes Therapeutics Inc. | BOLD | Morrison Scott W Director | 10,000 | $38.65 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:33 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Morrison Scott W Director | 16,200 | $24.74 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:34 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP Chief Commercial Officer | 26,919 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:34 pm | N/A 2029-01-03 | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP Chief Commercial Officer | 87,750 | $22.01 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:35 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 261,458 | $60 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:35 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 171,814 | $60 | 0 (Indirect) | View |
| 2020-01-15 Disposition | 2020-01-15 1:35 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 143,569 | $9.4988 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:35 pm | N/A 2027-01-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 188,334 | $15.26 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:35 pm | N/A 2027-11-16 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 225,000 | $27.39 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:35 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R CEO | 177,450 | $24.74 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:36 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 89,695 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:36 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 18,086 | $0.7804 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:36 pm | N/A 2025-05-27 | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 5,605 | $2.1852 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:36 pm | N/A 2026-08-24 | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 9,000 | $15.03 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:36 pm | N/A 2027-10-08 | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 9,000 | $26.15 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:36 pm | N/A 2028-06-08 | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 10,000 | $38.65 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:36 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 16,200 | $24.74 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:37 pm | N/A 2027-01-01 | Audentes Therapeutics Inc. | BOLD | Smith Julie Director | 18,000 | $17.85 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:37 pm | N/A 2027-10-08 | Audentes Therapeutics Inc. | BOLD | Smith Julie Director | 9,000 | $26.15 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:37 pm | N/A 2028-06-08 | Audentes Therapeutics Inc. | BOLD | Smith Julie Director | 10,000 | $38.65 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:37 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Smith Julie Director | 16,200 | $24.74 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:38 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 183,384 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:38 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 3,829 | $2.7649 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:38 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 6,263 | $9.4988 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:38 pm | N/A 2027-01-25 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 73,781 | $15.26 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:38 pm | N/A 2027-11-16 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 75,000 | $27.39 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:38 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P CFO | 65,000 | $24.74 | 0 (Direct) | View |